Jump to search

March 2017arrow

UC Davis joins national consortium to find regenerative treatments for dental and craniofacial tissues

March 7, 2017

UC Davis will join other California research institutions in a three-year, $12 million effort to find regenerative treatments for dental, oral and craniofacial deformities and injuries.

UC Davis licenses novel compound that helps stem cells regenerate bone

March 3, 2017

The University of California, Davis, has reached a licensing agreement with Regenerative Arthritis and Bone Medicine (RABOME) for a class of drugs developed at the university that hold potential for treating diseases associated with bone loss and inflammatory arthritis.

July 2016arrow

UC Davis scientists awarded grant for rare genetic disorder research

July 21, 2016

The state stem cell agency, the California Institute for Regenerative Medicine (CIRM), today approved a $1.1 million grant to UC Davis for research aimed at developing a treatment for Angelman syndrome,  a rare, neurogenetic autism-spectrum disorder that occurs in one in 15,000 live births.


 

connect with us

Facebook icon  Twitter icon  YouTube icon  Pinterest icon  GooglePlus icon  LinkedIn icon